Molecular spreading and predictive value of preclinical IgE response to Phleum pratense in children with hay fever

Journal of Allergy and Clinical Immunology

Volumn 130, Issue 4, 2012, Pages

  Hatzler, Laura ^a   Panetta, Valentina ^a,b   Lau, Susanne ^a   Wagner, Petra ^a   Bergmann, Renate L ^c   Illi, Sabina ^d   Bergmann, Karl E ^e   Keil, Thomas ^f   Hofmaier, Stephanie ^a   Rohrbach, Alexander ^a   Bauer, Carl Peter ^g   Hoffman, Ute ^g   Forster, Johannes ^h   Zepp, Fred ⁱ   Schuster, Antje ⁱ   Wahn, Ulrich ^j   Matricardi, Paolo Maria ^a,f  

^a Departments of Paediatric Pneumology and Immunology   (Germany)

^b L'altrastatistica srl Consultancy and Training Biostatistics Office   (Italy)

^c Paediatrics and Obstetrics   (Italy)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e ROBERT KOCH INSTITUTE   (Germany)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^h Department of Internal Medicine and Cardiology St Josefs Hospital Freiburg   (Germany)

ⁱ UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^j HEINRICH HEINE UNIVERSITY   (Germany)

more..

Author keywords

Allergenic molecules; Allergic rhinitis; Children; Component resolved diagnosis; Component resolved therapy; Grass pollen; Hay fever; Immunoglobulin E; Phl p 1; Phleum pratense; Prediction; Timothy grass

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY;

ADOLESCENT; ARTICLE; BLOOD SAMPLING; CHILD; DISEASE SEVERITY; ENZYME ASSAY; FEMALE; FOLLOW UP; GRASS POLLEN; HAY FEVER; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR EVOLUTION; MOLECULAR RECOGNITION; PHLEUM PRATENSE; PREDICTOR VARIABLE; PRESCHOOL CHILD; PRIORITY JOURNAL; QUESTIONNAIRE; SCHOOL CHILD; SENSITIZATION;

EID: 84869128517     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2012.05.053     Document Type: Article

References (32)

1. Burney P, Malmberg E, Chinn S, Jarvis D, Luczynska C, Lai E. The distribution of total and specific serum IgE in the European Community Respiratory Health Survey. J Allergy Clin Immunol 1997;99:314-22.
2. Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J 2004;24:758-64.
3. Strachan D, Sibbald B, Weiland S, Ait-Khaled N, Anabwani G, Anderson HR, et al. Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: The International Study of Asthma and Allergies in childhood. Pediatr Allergy Immunol 1997;8:161-76.
4. Nathan R. The burden of allergic rhinitis. Allergy Asthma Proc 2007;28:3-9.
5. Bousquet J, Schunemann HJ, Zuberbier T, Bachert C, Baena-Cagnani CE, Bousquet PJ, et al. Development and implementation of guidelines in allergic rhinitis: An ARIA-GA2LEN paper. Allergy 2010;65:1212-21.
6. Frew AJ, Powell RJ, Corrigan CJ, Durham SR. UK Immunotherapy Study Group. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006;117:319-25.
7. Matricardi PM, Panetta V, Kuna P, Wahn U, Narkus A. Specific immunotherapy and pharmacotherapy in the treatment of seasonal allergic rhinoconjunctivitis: A comparison based on meta-analyses. J Allergy Clin Immunol 2011;128:791-9, e6.
8. Durham SR, Walker SM, Varga EM, Jacobson MR, O'Brien F, Noble W, et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999; 341:468-75.
9. Plaut M, Valentine MD. Clinical practice. Allergic rhinitis. N Engl J Med 2005; 353:1934-44.
10. Adkinson NF Jr, Eggleston PA, Eney D, Goldstein DO, Schuberth KC, Bacon JR, et al. A controlled trial of immunotherapy for asthma in allergic children. N Engl J Med 1997;336:324-31.
11. Focke M, Marth K, Flicker S, Valenta R. Heterogeneity of commercial timothy grass pollen extracts. Clin Exp Allergy 2008;38:1400-8.
12. Tripodi S, Frediani T, Lucarelli S, Macri F, Pingitore G, Di Rienzo Businco A, et al. Molecular profiles of IgE to Phleum pratense in children with grass pollen allergy: Implications for specific immunotherapy. J Allergy Clin Immunol 2011; 129:834-9, e8.
13. Valenta R, Lidholm J, Niederberger V, Hayek B, Kraft D, Gronlund H. The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT). Clin Exp Allergy 1999;29:896-904.
14. Valenta R. The future of antigen-specific immunotherapy of allergy. Nat Rev Immunol 2002;2:446-53.
15. Andersson K, Lidholm J. Characteristics and immunobiology of grass pollen allergens. Int Arch Allergy Immunol 2003;130:87-107.
16. Mari A. Skin test with a timothy grass (Phleum pratense) pollen extract vs. IgE to a timothy extract vs. IgE to rPhl p 1, rPhl p 2, nPhl p 4, rPhl p 5, rPhl p 6, rPhl p 7, rPhl p 11, and rPhl p 12: Epidemiological and diagnostic data. Clin Exp Allergy 2003;33:43-51.
17. Bergmann RL, Bergmann KE, Lau-Schadensdorf S, Luck W, Dannemann A, Bauer CP, et al. Atopic diseases in infancy. The German multicenter atopy study (MAS- 90). Pediatr Allergy Immunol 1994;5(suppl):19-25.
18. Asher MI, Keil U, Anderson HR, Beasley R, Beasley R, Crane J, Martinez F, et al. International Study of Asthma and Allergies in Childhood (ISAAC): Rationale and methods. Eur Respir J 1995;8:483-91.
19. Hiller R, Laffer S, Harwanegg C, Huber M, Schmidt WM, Twardosz A, et al. Microarrayed allergen molecules: Diagnostic gatekeepers for allergy treatment. FASEB J 2002;16:414-6.
20. Petersen A, Bufe A, Schlaak M, Becker VM. Characterisation of the allergen group VI in timothy grass (Phl p 6). I. Immunological and biochemical studies. Int Arch Allergy Immunol 1995;108:49-54.
21. Kellberger J, Dressel H, Vogelberg C, et al. Prediction of the incidence and persistence of allergic rhinitis in adolescence: A prospective cohort study. J Allergy Clin Immunol 2012;129:397-402, e1-3.
22. Schafer T, Wolke G, Ring J, Wichmann HE, Heinrich J. Allergic sensitization to cat in childhood as major predictor of incident respiratory allergy in young adults. Allergy 2007;62:1282-7.
23. Rossi RE, Monasterolo G, Monasterolo S. Measurement of IgE antibodies against purified grass-pollen allergens (Phl p 1, 2, 3, 4, 5, 6, 7, 11, and 12) in sera of patients allergic to grass pollen. Allergy 2001;56:1180-5.
24. Dolecek C, Vrtala S, Laffer S, Steinberger P, Kraft D, Scheiner O, et al. Molecular characterization of Phl p II, a major timothy grass (Phleum pratense) pollen allergen. FEBS Lett 1993;335:299-304.
25. Eifan AO, Shamji MH, Durham SR. Long-term clinical and immunological effects of allergen immunotherapy. Curr Opin Allergy Clin Immunol 2011;11:586-93.
26. Valenta R, Twaroch T, Swoboda I. Component-resolved diagnosis to optimize allergen-specific immunotherapy in the Mediterranean area. J Investig Allergol Clin Immunol 2007;17(suppl):36-40.
27. Melioli G, Marcomini L, Agazzi A, Bazurro G, Tosca M, Rossi GA, et al. The IgE repertoire in children and adolescents resolved at component level: A crosssectional study. Pediatr Allergy Immunol 2012;23:433-40.
28. Chabre H, Gouyon B, Huet A, Baron-Bodo V, Nony E, Hrabina M, et al. Molecular variability of group 1 and 5 grass pollen allergens between Pooideae species: Implications for immunotherapy. Clin Exp Allergy 2010;40:505-19.
29. Rudenko M, Frew AJ. How important is it to include all epitopes in grass pollen extracts for specific immunotherapy? Clin Exp Allergy 2010;40: 365-7.
30. Johansen N, Weber RW, Ipsen H, Barber D, Broge L, Hejl C. Extensive IgE cross-reactivity towards the Pooideae grasses substantiated for a large number of grass-pollen-sensitized subjects. Int Arch Allergy Immunol 2009;150: 325-34.
31. Westritschnig K, Horak F, Swoboda I, Balic N, Spitzauer S, Kundi M, et al. Different allergenic activity of grass pollen allergens revealed by skin testing. Eur J Clin Invest 2008;38:260-7.
32. Weber RW. Patterns of pollen cross-allergenicity. J Allergy Clin Immunol 2003; 112:229-39.